These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 9278315)
1. The proliferative in vivo activities of lpr double-negative T cells and the primary role of p59fyn in their activation and expansion. Balomenos D; Rumold R; Theofilopoulos AN J Immunol; 1997 Sep; 159(5):2265-73. PubMed ID: 9278315 [TBL] [Abstract][Full Text] [Related]
2. Suppression of autoimmune disease and of massive lymphadenopathy in MRL/Mp-lpr/lpr mice lacking tyrosine kinase Fyn (p59fyn). Takahashi T; Yagi T; Kakinuma S; Kurokawa A; Okada T; Takatsu K; Aizawa S; Katagiri T J Immunol; 1997 Sep; 159(5):2532-41. PubMed ID: 9278347 [TBL] [Abstract][Full Text] [Related]
3. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse. Zhou T; Bluethmann H; Eldridge J; Berry K; Mountz JD J Immunol; 1993 Apr; 150(8 Pt 1):3651-67. PubMed ID: 7682246 [TBL] [Abstract][Full Text] [Related]
4. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha. Rifkin IR; Channavajhala PL; Kiefer HL; Carmack AJ; Landesman-Bollag E; Beaudette BC; Jersky B; Salant DJ; Ju ST; Marshak-Rothstein A; Seldin DC J Immunol; 1998 Nov; 161(10):5164-70. PubMed ID: 9820486 [TBL] [Abstract][Full Text] [Related]
5. Evidence for early onset, polyclonal activation of T cell subsets in mice homozygous for lpr. Giese T; Davidson WF J Immunol; 1992 Nov; 149(9):3097-106. PubMed ID: 1383337 [TBL] [Abstract][Full Text] [Related]
6. In CD8+ T cell-deficient lpr/lpr mice, CD4+B220+ and CD4+B220- T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes. Giese T; Davidson WF J Immunol; 1995 May; 154(10):4986-95. PubMed ID: 7537297 [TBL] [Abstract][Full Text] [Related]
7. Intestinal intraepithelial lymphocyte T cells are resistant to lpr gene-induced T cell abnormalities. Aicher WK; Fujihashi K; Taguchi T; McGhee JR; Yamamoto M; Eldridge JH; Gay S; Kiyono H Eur J Immunol; 1992 Jan; 22(1):137-45. PubMed ID: 1346108 [TBL] [Abstract][Full Text] [Related]
8. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR. Giese T; Allison JP; Davidson WF J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618 [TBL] [Abstract][Full Text] [Related]
10. Reversal of hyporesponsiveness in lpr CD4-CD8- T cells is achieved by induction of cell cycling and normalization of CD2 and p59fyn expression. Clements JL; Wolfe J; Cooper SM; Budd RC Eur J Immunol; 1994 Mar; 24(3):558-65. PubMed ID: 7510235 [TBL] [Abstract][Full Text] [Related]
11. Expansion of the population of double negative CD4-8- T alpha beta-cells in the liver is a common feature of autoimmune mice. Masuda T; Ohteki T; Abo T; Seki S; Nose S; Nagura H; Kumagai K J Immunol; 1991 Nov; 147(9):2907-12. PubMed ID: 1833460 [TBL] [Abstract][Full Text] [Related]
12. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production. Giese T; Davidson WF J Immunol; 1994 Feb; 152(4):2000-10. PubMed ID: 8120404 [TBL] [Abstract][Full Text] [Related]
13. CD2-CD4-CD8- lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+CD8+ thymic precursor. Landolfi MM; Van Houten N; Russell JQ; Scollay R; Parnes JR; Budd RC J Immunol; 1993 Jul; 151(2):1086-96. PubMed ID: 7687614 [TBL] [Abstract][Full Text] [Related]
14. CD2 expression correlates with proliferative capacity of alpha beta + or gamma delta + CD4-CD8- T cells in lpr mice. Budd RC; Russell JQ; van Houten N; Cooper SM; Yagita H; Wolfe J J Immunol; 1992 Feb; 148(4):1055-64. PubMed ID: 1346621 [TBL] [Abstract][Full Text] [Related]
15. Constitutive tyrosine phosphorylation of the vav proto-oncogene product in MRL/Mp-lpr/lpr mice. Mimura T; Minota S; Nojima Y; Morino N; Hamasaki K; Furuya H; Yazaki Y J Immunol; 1997 Mar; 158(6):2977-83. PubMed ID: 9058837 [TBL] [Abstract][Full Text] [Related]
16. Selection of the T cell receptor repertoire in Lpr mice. Herron LR; Eisenberg RA; Roper E; Kakkanaiah VN; Cohen PL; Kotzin BL J Immunol; 1993 Oct; 151(7):3450-9. PubMed ID: 8376785 [TBL] [Abstract][Full Text] [Related]
17. Expansion of an unusual population of Gr-1+CD3int cells in the lymph nodes and other peripheral organs of mice carrying the lpr gene. Honda S; Takeda K; Narita J; Koya T; Kawamura T; Kuwano Y; Watanabe H; Arakawa M; Abo T Cell Immunol; 1997 May; 177(2):144-53. PubMed ID: 9178641 [TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of the very early activation antigen on MRL/Mp-lpr/lpr lymphocytes. Sobel ES; Yokoyama WM; Shevach EM; Eisenberg RA; Cohen PL J Immunol; 1993 Jan; 150(2):673-82. PubMed ID: 8380429 [TBL] [Abstract][Full Text] [Related]
19. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells. Tago F; Tsukimoto M; Nakatsukasa H; Kojima S Radiat Res; 2008 Jan; 169(1):59-66. PubMed ID: 18159952 [TBL] [Abstract][Full Text] [Related]
20. Elucidation of the protein kinase C-dependent apoptosis pathway in distinct subsets of T lymphocytes in MRL-lpr/lpr mice. Ohkusu K; Isobe K; Hidaka H; Nakashima I Eur J Immunol; 1995 Nov; 25(11):3180-6. PubMed ID: 7489761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]